£2.0M
Anthemis Exponential Ventures led the seed round with participation from APEX Ventures and Entrepreneur First.
N
Novoic
Novoic develops speech-based artificial intelligence algorithms for early neurological disease detection.
£2.0MTotal raised
Novoic is a digital biotechnology company developing speech-based artificial intelligence algorithms to detect and monitor neurological conditions. The firm focuses on creating software as a medical device for early diagnosis.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Novoic's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
EF
Emil Fristed
co-founder and CEO
Emil is the co-founder and CEO of Novoic. He previously worked as an assistant research scientist in the King Group at the University of Oxford.
LinkedIn